Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$BNTX Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.99 down -45.48% YoY • Reported revenue of $1.49B down -16.21% YoY • BioNTech raised its FY 2026 revenue guidance midpoint to 17T; adjusted R&D expenses guidance of 20T and adjusted SG&A expenses guidance of 700.8B remain unchanged for the full year.

Price since post

Full Details

Advertisement|Remove ads.